Summary by Futu AI
Tonix Pharmaceuticals Holding Corp. (Tonix) has announced its Annual Meeting of Shareholders to be held virtually on May 22, 2024. The meeting will address several key proposals, including the election of eight director nominees, the ratification of EisnerAmper LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, and a reverse stock split proposal. The reverse stock split aims to authorize the Board of Directors to effect a reverse stock split of the company's common stock at a ratio not less than one-for-two and not greater than one-for-fifty, with the exact ratio to be determined by the Board within one year after stockholder approval. Additionally, the meeting will seek approval for the repricing of up to 94,398,656 shares of common stock issuable upon the exercise of warrants, in compliance with Nasdaq Listing Rule 5635(d). Shareholders of record as of March 25, 2024, are entitled to attend and vote at the meeting. Proxy materials will be furnished to shareholders on or about April 16, 2024.